Dr. Dylan M. Zylla

Hematology | Oncology
2001 Blaisdell Ave, 
Minneapolis, MN 
Accepting New Patients
Offers Telehealth
2001 Blaisdell Ave, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dylan Zylla is a Hematologist and an Oncologist in Minneapolis, Minnesota. Dr. Zylla is rated as an Experienced provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Multiple Myeloma, and Familial Pancreatic Cancer. Dr. Zylla is currently accepting new patients.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in MN
Hospital Affiliations
Park Nicollet Methodist Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

PARK NICOLLET CLINIC
2001 Blaisdell Ave, Minneapolis, MN 55404
Other Locations
PARK NICOLLET CLINIC
3800 Park Nicollet Blvd, Mailstop 61n01i, St Louis Park, MN 55416
PARK NICOLLET CLINIC
15111 Twelve Oaks Ctr Dr, Minnetonka, MN 55305
PARK NICOLLET CLINIC
6500 Excelsior Blvd, St Louis Park, MN 55426
PARK NICOLLET CLINIC
15800 95th Ave N, Maple Grove, MN 55369
PARK NICOLLET CLINIC
8455 Flying Cloud Dr, Eden Prairie, MN 55344
PARK NICOLLET CLINIC
4155 County Rd 101, Plymouth, MN 55446
PARK NICOLLET CLINIC
14000 Fairview Dr, Burnsville, MN 55337
PARK NICOLLET CLINIC
6000 Earle Brown Dr, Brooklyn Center, MN 55430
PARK NICOLLET CLINIC
1885 Plaza Dr, Eagan, MN 55122
PARK NICOLLET CLINIC
5320 Hyland Greens Dr, Bloomington, MN 55437
PARK NICOLLET CLINIC
250 Central Ave N, Wayzata, MN 55391
PARK NICOLLET CLINIC
8401 Golden Valley Rd, Golden Valley, MN 55427

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug
Study Drug: Entrectinib
Study Phase: Phase 2
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2025
Intervention Type: Drug
Study Drugs: alpelisib, nab-paclitaxel
Study Phase: Phase 3
Double-Blinded, Placebo-Controlled Trial to Explore the Anti-Androgen, Ketoconazole, for Treating Patients With an Ongoing Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash
Double-Blinded, Placebo-Controlled Trial to Explore the Anti-Androgen, Ketoconazole, for Treating Patients With an Ongoing Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Drug
Study Phase: Early Phase 1
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Enrollment Status: Completed
Publish Date: June 29, 2025
View 3 Less Clinical Trials

26 Total Publications

Association of Financial Wellness with Patterns of Medical Cannabis Use and Patient-Reported Outcomes in Adults with Cancer.
Association of Financial Wellness with Patterns of Medical Cannabis Use and Patient-Reported Outcomes in Adults with Cancer.
Journal: Cannabis (Albuquerque, N.M.)
Published: February 19, 2025
Similar Doctors
Advanced in Hemochromatosis
Dr. Gauri G. Nagargoje
Hematology Oncology | Oncology | Hematology
Advanced in Hemochromatosis
Dr. Gauri G. Nagargoje
Hematology Oncology | Oncology | Hematology

Minnesota Oncology Hematology PA

11850 Blackfoot St Nw, Suite 100, 
Coon Rapids, MN 
 (16.0 miles away)
763-519-7440
Languages Spoken:
English, Hindi, Marathi
See accepted insurances
Accepting New Patients

Gauri Nagargoje is a Hematologist Oncology specialist and an Oncologist in Coon Rapids, Minnesota. Dr. Nagargoje is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. Her top areas of expertise are Familial Pancreatic Cancer, Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), and Lung Cancer. Dr. Nagargoje is currently accepting new patients.

Advanced in Hemochromatosis
Dr. Gregory M. Vercellotti
Hematology Oncology | Hematology | Oncology
Advanced in Hemochromatosis
Dr. Gregory M. Vercellotti
Hematology Oncology | Hematology | Oncology

Fairview Express Care

500 Harvard St Se, 
Minneapolis, MN 
 (2.4 miles away)
763-525-1746
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregory Vercellotti is a Hematologist Oncology specialist and a Hematologist in Minneapolis, Minnesota. Dr. Vercellotti is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Vercellotti is currently accepting new patients.

Advanced in Hemochromatosis
Dr. Mohammed K. Nashawaty
Hematology Oncology | Oncology
Advanced in Hemochromatosis
Dr. Mohammed K. Nashawaty
Hematology Oncology | Oncology

Minnesota Oncology Hematology PA

6545 France Ave S, Suite 210, 
Edina, MN 
 (5.9 miles away)
952-928-2900
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mohammed Nashawaty is a Hematologist Oncology specialist and an Oncologist in Edina, Minnesota. Dr. Nashawaty is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Myeloproliferative Neoplasms (MPN), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, and Thrombocytopenia. Dr. Nashawaty is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zylla's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 87 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile